Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/31/2011CN101322705B Applications of koumine in preparing medicament for treating chronic ache
08/31/2011CN101317832B Oral administration nano-drug administration system of resveratrol
08/31/2011CN101316818B 3-amino-1-arylpropyl indoles and aza-substituted indoles
08/31/2011CN101289482B Cambogic acid glycoside derivates and the like, preparation and uses thereof
08/31/2011CN101268051B Isotopically substituted proton pump inhibitors
08/31/2011CN101249095B Preparation of emulsifiable paste for containing decoloring agent, tretinoin and skinniness steroids
08/31/2011CN101228135B Pyridazinone derivatives as thyroid hormone receptor agonists
08/31/2011CN101223167B Novel heteroaryl fused cyclic amines
08/31/2011CN101219992B Crystalline forms of pitavastatin calcium
08/31/2011CN101204202B Ruminant granular humic acid feed
08/31/2011CN101203489B Oxindole derivatives
08/31/2011CN101200469B Separation of regioisomers of metal phthalocyanines
08/31/2011CN101181320B Dyer's woad root vitamin C effervescent formulation
08/31/2011CN101157668B Substituted cinnamic acid nitrogen-containing derivative having tumor cytotoxic activity
08/31/2011CN101155808B Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
08/31/2011CN101151019B Pharmaceutical preparation of n -[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl] acetamide
08/31/2011CN101121698B Diarylmiazines derivatives, preparation method and use thereof
08/31/2011CN101115719B Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
08/31/2011CN101095716B Use of cortex eucommiae total polyoses in the preparing of the medicine for preventing and treating systematic lupus erythematosus
08/31/2011CN101080227B Combinations of therapeutic agents for treating cancer
08/31/2011CN101062046B Use of saikosaponin A as unique effective ingredient in preparing medicine for suppressing fibroblast proliferation of liver
08/31/2011CN101032488B Transdermal composition using piroxicam-inorganic complex and patch system comprising the same
08/31/2011CN101031303B Pharmaceutical compositions comprising zd6474
08/31/2011CN101016391B Polysaccharides nano material with antibiotic function, preparing method and application thereof
08/30/2011US8008525 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits
08/30/2011US8008510 Metalloprotein inhibitors
08/30/2011US8008506 Indazole compounds
08/30/2011US8008505 Indazole or 4,5,6,7-tetrahydro-indazole derivatives
08/30/2011US8008503 Methyl-benzimidazole derivatives
08/30/2011US8008502 Thiazoline acid derivatives
08/30/2011US8008501 Inhibit the Immunoglobulin E (IgE) receptor signaling cascade; associated with mast and/or basophil cell degranulation such as allergic diseases, scarring, inflammation; e.g. 5-Methyl-3-phenyl-4-isoxazolecarboxylic acid, 2-methyl-4-quinolinyl Ester
08/30/2011US8008491 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders
08/30/2011US8008488 Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligands
08/30/2011US8008483 sEH inhibitors and their use
08/30/2011US8008476 Room temperature stable agarose solutions
08/30/2011US8008473 RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA)
08/30/2011US8008472 RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA)
08/30/2011US8008471 Nucleic acids for inhibiting hairless protein expression and methods of use thereof
08/30/2011US8008469 Antisense compound for inducing immunological tolerance
08/30/2011US8008435 Polymer stabilized neuropeptides
08/30/2011US8008353 Alzheimer's disease; small molecule amine salts
08/30/2011US8008352 Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/30/2011US8008351 Methods for prophylaxis or treatment of conditions associated with cortical spreading depression
08/30/2011US8008350 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
08/30/2011US8008349 Stable pharmaceutical preparation comprising levothyroxine sodium, gelatin and fillers and which is free of organic solvent residues
08/30/2011US8008348 Treating muscle wasting with selective androgen receptor modulators
08/30/2011US8008347 Methoxypolyethylene glycol thioester chelate and uses thereof
08/30/2011US8008346 Chemotherapeutic agents for inhibition of protein translation
08/30/2011US8008345 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics
08/30/2011US8008344 Compounds for the inhibition of histone deacetylase
08/30/2011US8008342 Ion channel modulating compounds and uses thereof
08/30/2011US8008341 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
08/30/2011US8008340 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase I
08/30/2011US8008339 Non-fluorescent chlorophyll catabolites
08/30/2011US8008338 Ketorolac tromethamine compositions for treating or preventing ocular pain
08/30/2011US8008337 Azabicyclo[3.2.0] hept-3-yl compounds, a process for their preparation and pharmaceutical compositions containing them
08/30/2011US8008336 Forming electronic material, semiconductors
08/30/2011US8008335 Indole and benzimidazole derivatives
08/30/2011US8008334 Bis-heterocyclic imidazolyl compounds
08/30/2011US8008333 Inducing ovulation; increasing response to follicle stimulating hormone
08/30/2011US8008332 Substituted indazoles as glucokinase activators
08/30/2011US8008331 Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors
08/30/2011US8008330 Combinations comprising epothilones and pharmaceutical uses thereof
08/30/2011US8008329 Method of treating or preventing osteoporosis comprising administering to a patient in need thereof an effective amount of pharmacuetical composition comprising benzamidine derivative or it's salt, and bisphosphonate
08/30/2011US8008328 Administering combination of niacin and meloxicam; reducing prostaglandin levels
08/30/2011US8008327 Indazole compounds as CCR1 receptor antagonists
08/30/2011US8008326 4-benzyledene-piperidin derivatives
08/30/2011US8008325 Plasma carboxypeptidase B inhibitors
08/30/2011US8008324 Antitumor agents; N-propargyl-N-(2-methyl-6-quinolyl)-[1-(4-chlorobenzyl)indol-3-yl]glyoxylamide
08/30/2011US8008323 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
08/30/2011US8008322 Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use
08/30/2011US8008321 Imidazo[1,5-a]pyridin-3-yl)(3-methoxy-4-nitrophenyl)methanone; a and b fibroblast growth factor receptors (FGFR) antagonist; anticarcinogenic, antitumor: lung, breast, prostate, melanomas, gliomas; antiinflammatory, vascular smooth muscle cells: atherosclerosis, restenosis, stent and bypass complications
08/30/2011US8008320 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors
08/30/2011US8008319 Treatment of colorectal polyps with imidazoquinoline derivatives
08/30/2011US8008317 Inhibitors of akt activtiy
08/30/2011US8008316 Azonafide derived tumor and cancer targeting compounds
08/30/2011US8008315 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/30/2011US8008314 Method of recovering cyanopyridines
08/30/2011US8008313 Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseases
08/30/2011US8008312 CXCR4 antagonists for the treatment of HIV infection
08/30/2011US8008310 Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same
08/30/2011US8008309 Inhibitors of bruton's tyrosine kinase
08/30/2011US8008308 Phosphonate compounds
08/30/2011US8008307 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
08/30/2011US8008306 Quinoline compounds
08/30/2011US8008305 TAAR1 ligands
08/30/2011US8008304 Substituted propiolic acid amides and their use for producing drugs
08/30/2011US8008303 Biphenyl derivatives and their use in treating hepatitis C
08/30/2011US8008302 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis
08/30/2011US8008301 Histamine H3 receptor agents, preparation and therapeutic uses
08/30/2011US8008300 Therapeutic agents useful for treating pain
08/30/2011US8008299 Urotensin II receptor antagonists
08/30/2011US8008298 Pyrrolopyrazine kinase inhibitors
08/30/2011US8008297 Lysine based compounds
08/30/2011US8008296 Histamine H3 receptor agents, preparation and therapeutic uses
08/30/2011US8008295 Tyrosine kinase inhibitors
08/30/2011US8008294 Citrate salt of an indole derivative and its pharmaceutical use
08/30/2011US8008293 Bicyclic oxomorpholine derivative
08/30/2011US8008292 Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity
08/30/2011US8008291 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists